• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about ACAD

Recent news which mentions ACAD

< Previous 1 2 3 4 5 6 7 Next >
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022
November 04, 2022
Tickers ACAD ACDC AEIS ANET
Tags FTDR Initiation DMTK
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Tickers ABMD ACAD AKTX AMC
Tags AMC RPT TIL
From Benzinga
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
Tickers ACAD ADMP AGEN ALEC
Tags HAE HZN BNTX
From Benzinga
U.S. FDA Accepts Acadia's Filing For Rett Syndrome Candidate Under Priority Review
September 12, 2022
Tickers ACAD
Tags General News Market News
From Benzinga
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
August 31, 2022
Tickers ACAD AMGN AMLX AXSM
Tags SPPI FOLD HRTX
From Benzinga
ACADIA Pharmaceuticals's Return On Capital Employed Insights
August 29, 2022
Tickers ACAD
Tags Benzinga Market News ACAD
From Benzinga
Acadia Terminates Painkiller, Cancer Candidate After Disappointing Data
August 09, 2022
Tickers ACAD VRTX
Tags General News VRTX
From Benzinga
ACADIA Pharmaceuticals Faces Several Price Target Cuts After Q2 Results, But This Analyst Disagrees
August 09, 2022
Tickers ACAD
Tags News Analyst Ratings Pre/Market Outlook
From Benzinga
NVIDIA To $240? Here Are 5 Other Price Target Changes For Tuesday
August 09, 2022
Tickers ACAD BC CRSP MNDY
Tags Markets ACAD NVDA
From Benzinga
ACADIA Pharmaceuticals: Q2 Earnings Insights
August 08, 2022
Tickers ACAD
Tags Benzinga ACAD Market News
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
August 08, 2022
Tickers ACAD AZEK BALL BCRX
Tags WDC HSCS Upgrades
From Benzinga
8 Analysts Have This to Say About ACADIA Pharmaceuticals
August 05, 2022
Tickers ACAD
Tags Analyst Ratings Benzinga Market News
From Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
August 05, 2022
Tickers ACAD AKBA ALDX AMRX
Tags Market News Movers MYOV
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
August 05, 2022
Tickers AAWW ACAD ARRY ATI
Tags XRAY CCXI CVCO
From Benzinga
Benzinga Before The Bell: Should Investors Worry About Tesla's China Sales, Gold Back In Focus, Nio Smartphone Could Soon Be A Reality Other Top Financial Stories Friday, August 5
August 05, 2022
Tickers AAPL ACAD COIN INTC
Tags Market News SPCE AAPL
From Benzinga
FDA Asks For Additional Study For Acadia's Pimavanserin In Alzheimer's-Associated Delusions
August 05, 2022
Tickers ACAD
Tags Movers Health Care Market News
From Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
August 04, 2022
Tickers ABUS ACAD ADAP AGIO
Tags ACAD AZN Financing
From Benzinga
Biotech Investors: August's Key PDUFA Catalysts You Must Know
July 31, 2022
Tickers ACAD AMGN AXSM BGNE
Tags INCY AMGN MYOV
From Benzinga
The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings
July 19, 2022
Tickers ACAD APLS AVDL AZN
Tags Trading Ideas CELU DSNKY
From Benzinga
Recap of Monday's Biotech Catalysts - End of the Day Summary
July 18, 2022
Tickers ABBV ACAD ACER APYX
Tags ELDN RARE MEIP
From Benzinga
Acadia Seeks FDA Approval For Genetic Neurological Disorder Candidate
July 18, 2022
Tickers ACAD
Tags Market News Health Care News
From Benzinga
Where ACADIA Pharmaceuticals Stands With Analysts
July 11, 2022
Tickers ACAD
Tags Benzinga Market News ACAD
From Benzinga
67 Biggest Movers From Yesterday
June 22, 2022
Tickers ACAD ACER ALV AMED
Tags HCTI DC KRBP
From Benzinga
Analysts Try To See Beyond Acadia's Alzheimer's Disease Psychosis
June 21, 2022
Tickers ACAD
Tags Market News Health Care Analyst Ratings
From Benzinga
Why Is Acadia Pharmaceuticals (ACAD) Stock Down 33% Today?
June 21, 2022
Tickers ACAD
Tags Today's Market ACAD Market News
From InvestorPlace
Nasdaq Rises 2.5%; ACADIA Pharmaceuticals Shares Plummet
June 21, 2022
Tickers ACAD BHAT BPT CNVY
Tags Homebuilding News BHAT
From Benzinga
Dow Jumps 550 Points; Convey Health Solutions Shares Spike Higher
June 21, 2022
Tickers ACAD ARVL BHAT CNVY
Tags Homebuilding News BHAT
From Benzinga
Why Acadia Pharmaceuticals Stock Is Crashing Today
June 21, 2022
Tickers ACAD
Tags Recent Press Releases ACAD Market News
From Motley Fool
45 Stocks Moving In Tuesday's Mid-Day Session
June 21, 2022
Tickers ACAD ALV AMED ARBK
Tags DVA LBPS Movers
From Benzinga
U.S. Markets Open Higher; Lennar Earnings Top Views
June 21, 2022
Tickers ACAD BKSY CHWY CNVY
Tags Market News LEN ACAD
From Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap